Back

Longitudinal multiomic network rewiring at the complement coagulation interface in post-acute sequelae of COVID 19 (PASC)

Ward, B.; Belkhir, L.; Balligand, J.-L.; Cani, P. D.; De Greef, J.; Dewulf, J. P.; Gatto, L.; Haufroid, V.; Kabamba, B.; Vertommen, D.; Yombi, J. C.; Elens, L.; Bommer, G.; Bamps, L.

2026-07-16 infectious diseases
10.64898/2026.07.14.26358048 medRxiv
Show abstract

Background. Post acute sequelae of COVID 19 (PASC) is clinically heterogeneous and mechanistically unresolved, and single-analyte studies have struggled to explain it. Methods. We profiled matched plasma proteomics, metabolomics and whole-blood transcriptomics at acute infection and convalescence (mean 86 days later) in a Belgian cohort, using linear mixed models, multiomic gene-set enrichment, and a degree-matched differential-correlation approach to quantify how each node's interactions were rewired between patients who developed PASC and those who recovered; seven axis proteins were additionally quantified by multiplex immunoassay as orthogonal validation. Findings. Single omic testing yielded few FDR significant features, yet multi-omic enrichment showed sustained complement cascade involvement from acute illness to follow-up in PASC. Correlation networks re-organised topologically toward C3 and lost the immunoglobulin V gene coexpression seen in recovery. The most rewired nodes, heparin cofactor II (SERPIND1), alpha 1 antitrypsin (SERPINA1), complement factor H related 5 (CFHR5), prothrombin/thrombin (F2) and immunoglobulin V gene transcripts (notably IGLV3 21), changed in their co-expression structure rather than in abundance. In multiplex validation, acute CRP was elevated in patients who developed PASC (FDR = 0.012), whereas the directly measured abundances of the network-nominated proteins were unchanged. Interpretation. These trajectory aware, cross omic networks nominate a thrombo inflammatory axis in which complement and coagulation regulation remain dysregulated in PASC at the level of wiring rather than abundance, providing a systems framework for validation and for exploring interventions at the complement coagulation platelet interface.

Matching journals

The top 10 journals account for 50% of the predicted probability mass.

1
Nature Communications
5641 papers in training set
Top 17%
10.5%
2
JCI Insight
277 papers in training set
Top 0.3%
9.6%
3
eLife
5828 papers in training set
Top 25%
4.8%
4
eBioMedicine
183 papers in training set
Top 0.5%
4.3%
5
Cell Reports Medicine
153 papers in training set
Top 0.5%
4.2%
6
Nature Immunology
79 papers in training set
Top 0.6%
4.2%
7
The Journal of Infectious Diseases
202 papers in training set
Top 0.8%
4.2%
8
Frontiers in Immunology
638 papers in training set
Top 3%
4.0%
9
Cell Reports
1498 papers in training set
Top 13%
3.2%
10
EMBO Molecular Medicine
95 papers in training set
Top 0.3%
3.1%
50% of probability mass above
11
iScience
1154 papers in training set
Top 9%
2.7%
12
Nature Microbiology
155 papers in training set
Top 1%
2.7%
13
Scientific Reports
3612 papers in training set
Top 40%
2.6%
14
Nature Medicine
125 papers in training set
Top 1%
2.4%
15
Science Advances
1243 papers in training set
Top 14%
2.4%
16
Communications Medicine
113 papers in training set
Top 1%
2.4%
17
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 26%
1.9%
18
Journal of Clinical Investigation
179 papers in training set
Top 3%
1.9%
19
Life Science Alliance
285 papers in training set
Top 4%
1.5%
20
Genome Medicine
183 papers in training set
Top 3%
1.4%
21
Immunity
67 papers in training set
Top 1%
1.1%
22
mBio
833 papers in training set
Top 10%
1.0%
23
BMC Medicine
176 papers in training set
Top 4%
1.0%
24
Wellcome Open Research
67 papers in training set
Top 1%
0.9%
25
Journal of Translational Medicine
57 papers in training set
Top 2%
0.9%
26
PLOS Biology
486 papers in training set
Top 12%
0.8%
27
Science Signaling
65 papers in training set
Top 2%
0.8%
28
Med
39 papers in training set
Top 0.7%
0.8%
29
Clinical Immunology
21 papers in training set
Top 0.5%
0.6%
30
Science Translational Medicine
127 papers in training set
Top 4%
0.6%